Tempus AI, Inc (TEM) - Cash on Hand per Share

Tempus AI Inc - graphic logo of issuer TEM

The cash position per share for Tempus AI, Inc (TEM) reflects the current liquid reserve, where 3.52 is the current value of the metric. Revenue growth is driven by the sale of unique medical big data to pharma behemoths. The business foundation relies on AI-driven genomic analysis for targeted cancer therapy. The implementation of digital diagnostics and the monetization of an extensive clinical data library are creating positive momentum.

Cash per Share: Tempus AI Inc (TEM) for 06/15/2024 - 11/20/2026

Comprehensive metric breakdowns and analytics for Tempus AI, Inc (TEM)

- share price and consensus valuation forecast:
- market capitalization indicators:
- cash availability and cash flow indicators:
General company analysis:Tempus AI, TEM
Product sample of Tempus Labs

To identify fundamental stability drivers, an investor analyzes the ratio of total liquid assets to the number of shares outstanding. The quarterly trend of cash per share visualizes the size of the "safety cushion," which is critical for Tempus AI, Inc (TEM) given its high operational cash burn and uncertain timeline to break-even amid fierce competition in the AI sector.

Key competitors

QGEN - Cash Funds Volume per Share|Cash per Share IONS|RGEN - Cash on Hand per Share|Cash Funds per Share Avidity RNA|Cash per Share CRISPR Therapeutics Corp CRSP|GeneDx Corp - Cash per Share|Ultragenyx Pharma (RARE) - Cash per Single Share|beamtx.com (BEAM) - Cash Funds per Share|SRPT: Cash Calculated per Single Share|Cash per Single Share TWST|TXG - Cash Funds Volume per Share|Cash per Share NTLA|Cash Funds Calculated per Share Stoke Therapeutics|Cash Funds per Share BioLife Solutions BLFS|Wave Life Sciences (WVE) - Cash on Hand per Share|Maze Therapeutics, Inc. - Cash per Share|Cash Funds Calculated per Share Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Cash Funds per Share|TSHA: Cash Calculated per Single Share|Cash Funds per Share uniQure Pharma|MGTX - Cash Funds Volume per Share|Cash per Share RGNX|Cash Funds per Share SLDB (Solid Biosciences)|Ocugen Corp - Cash per Single Share|PACB: Cash Funds per Single Share|benitec.com - Cash per Share|DSGN - Cash per Share|RCKT: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology